Gene Therapy Market is expected to grow USD 558.7 million in 2024, at a exponential CAGR 14.6% from 2018 to 2024
The Global Gene Therapy Market is expected to grow significantly from USD 215.0 million in 2017 to USD 558.7 million in 2024, at a exponential CAGR 14.6% from 2018 to 2024.
The Global Gene Therapy Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2024. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2024.
We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/12336
Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Gene Therapy Market.
The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.
The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).
What is the market size in 2018 and the growth rate of the Global Gene Therapy Market?
What is the market drivers, restrains, opportunities governing the Global Gene Therapy Market?
Which are the largest and the fastest growing segments in the Global Gene Therapy Market?
Who are the key players operating in the market and their market position?
What is the pipeline scenario, drug pricing analysis and technological development in the market?
View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/global-gene-therapy-market-emr-12336
This growth is attributed to the growing number of clinical trial and increasing funding for research and development activities. Moreover, increasing awareness regarding gene therapy and growing number of chronic and genetics diseases are propelling the growth of the industry. The years used for the assessment are as follows:
Historical year: 2014, 2015, 2016
Base year: 2017
Forecast period: 2018 ndash; 2024
The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;
Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
Interacting with key opinion leaders of the market and developing data points based on interaction with them
Study of past trends in the market and their year on year Impact on the market size and share
Analyzing the collected data points
Bridging the data points to calculate the total global gene therapy market and its various segments
Anticipating potential risks
Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global gene therapy market
Finalizing the overall size and share of the global gene therapy market
To analyze market trends, opportunities, drivers, and restraints associated with the global gene therapy market
To study market response with respect to the mergers and acquisitions in the industry
To profile key companies operating in the global gene therapy market and provide their competitive landscape
The research scope for Global Gene Therapy Market is as follows:
Germline Gene Therapy
Somatic Gene Therapy
By Vectors Type
Adeno Associated Virus
Herpes Simplex Virus
Rest of the World
The global gene therapy market is expected to grow significantly from USD 215.0 million in 2017 to USD 558.7 million in 2024, at a CAGR 14.6% from 2018 to 2024. This growth is attributed to the growing number of clinical trial and increasing funding for research and development activities. Moreover, increasing awareness regarding gene therapy and growing number of chronic and genetics diseases are propelling the growth of the industry.
On the basis of vectors type, the viral vectors hold the major share of the market in 2017. Based on application, the oncology diseases segment hold the major share of market due to growing number of cancer patients, as well as increasing number of research and development activities in this segment.
North America has witnessed to hold the maximum share of the global market and the trend is likely to continue over the forecast period. The growth is attributed to in this region growing number of peoples suffering from chronic diseases, and increasing number of clinical trials. Europe holds the second largest market share of gene therapy in 2017, owing to growing number of therapies approval as well as favorable government policies in this region. Asia-Pacific region is anticipated to witness the highest CAGR over the forecasted period.
Key players in global gene therapy market are Spark Therapeutics, Inc.; Bluebird bio, Inc.; ViroMed Co., Ltd.; Sanofi ; Advantagene, Inc.; Vical Inc.; Oxford BioMedica; Human Stem Cells Institute; GlaxoSmithKline plc.; Novartis AG; AveXis, Inc.; Editas Medicine; REGENXBIO Inc.
Table Of Contents
Global Gene Therapy Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation amp; Forecast 2024
CHAPTER 1. Market Scope and Methodology
1.1. Research methodology
1.2. Research scope amp; assumptions
1.3. List of data sources
CHAPTER 2. Executive Summary
2.1. Gene Therapy- Market Snapshot
CHAPTER 3. Industry Analysis
3.1. Market definition
3.2. Market segmentation
3.3. Key findings of the global gene therapy market
3.4. Value chain analysis
3.5. Market opportunities amp; trends
3.5.1. Market driver analysis
18.104.22.168. Growing demand for treatment and cure a wide range of genetic diseases
22.214.171.124. Increasing research and development activities
126.96.36.199. Growing awareness among people
188.8.131.52. Government and private funding support to the gene therapy
3.5.2. Market restraint analysis
184.108.40.206. Multigene disorders
220.127.116.11. High cost of genetic therapy treatment
3.5.3. Industry Analysis-Porters five forces of analysis
CHAPTER 4. Competitive Outlook
4.1. Competitive aanalysis
4.2. Competitive factors
4.3. Strategies adopted
CHAPTER 5. Global Gene Therapy Market Size and Forecast (2014 ndash; 2024)
5.1. Global Gene Therapy Market, By Type
5.1.1. Germline Gene Therapy
5.1.2. Somatic Gene Therapy
5.2. Global Gene Therapy Market, By Vectors Type
5.2.1. Viral Vectors
18.104.22.168. Adeno Associated Virus
22.214.171.124. Herpes Simplex Virus
126.96.36.199. Vaccinia Virus
5.2.2. Non-Viral Vectors
188.8.131.52. Gene Gun
184.108.40.206. Naked/Plasmid Vectors
5.3. Global Gene Therapy Market, By Application
5.3.1. Infections Disorders
5.3.2. Genetic Disorders
5.3.3. Rare Diseases
5.3.4. Oncology Diseases
5.3.5. Cardiovascular Disorders
5.3.6. Diabetes Mellitus
5.3.7. Neurological Disorders
5.3.8. Other Diseases
5.4. Global Gene Therapy Market, By Region
5.4.1. North America
5.4.4. Rest of the World (RoW)
CHAPTER 6. Global Gene Therapy Market, By Geography
6.1. North America Gene Therapy Market
6.1.1. North America Gene Therapy Market, By Type (USD Million)
6.1.2. North America Gene Therapy Market, By Vectors Type (USD Million)
6.1.3. North America Gene Therapy Market, By Application (USD Million)
6.1.4. North America Gene Therapy Market, By Country
6.2. Europe Gene Therapy Market
6.2.1. Europe Gene Therapy Market, By Type (USD Million)
6.2.2. Europe Gene Therapy Market, By Vectors Type (USD Million)
6.2.3. Europe Gene Therapy Market, By Application (USD Million)
6.2.4. Europe Gene Therapy Market, By Country
220.127.116.11. Rest of Europe
6.3. Asia-Pacific Gene Therapy Market
6.3.1. Asia-Pacific Gene Therapy Market, By Type (USD Million)
6.3.2. Asia-Pacific Gene Therapy Market, By Vectors Type (USD Million)
6.3.3. Asia-Pacific Gene Therapy Market, By Application (USD Million)
6.3.4. Asia-Pacific Gene Therapy Market, By Country
18.104.22.168. South Korea
22.214.171.124. Rest of Asia-Pacific
6.4. Middle East and Africa Gene Therapy Market
6.4.1. Middle East and Africa Gene Therapy Market, By Type (USD Million)
6.4.2. Middle East and Africa Gene Therapy Market, By Vectors Type (USD Million)
6.4.3. Middle East and Africa Gene Therapy Market, By Application (USD Million)
6.4.4. Middle East and Africa Gene Therapy Market, By Region
126.96.36.199. Middle East and Africa (MEA)
188.8.131.52. Latin America
CHAPTER 7. Key Players and Strategic Developments
7.1. Spark Therapeutics, Inc.
7.1.1. Business Overview
7.1.2. Product and Service Offering
7.1.3. Financial Overview
7.1.4. Strategic Developments
7.2. Bluebird bio, Inc.
7.2.1. Business Overview
7.2.2. Product and Service Offering
7.2.3. Financial Overview
7.2.4. Strategic Developments
7.3. ViroMed Co., Ltd.
7.3.1. Business Overview
7.3.2. Product and Service Offering
7.3.3. Financial Overview
7.3.4. Strategic Developments
7.4.1. Business Overview
7.4.2. Product and Service Offering
7.4.3. Financial Overview
7.4.4. Strategic Developments
7.5. Advantagene, Inc.
7.5.1. Business Overview
7.5.2. Product and Service Offering
7.5.3. Financial Overview
7.5.4. Strategic Developments
7.6. Vical Inc.
7.6.1. Business Overview
7.6.2. Product and Service Offering
7.6.3. Financial Overview
7.6.4. Strategic Developments
7.7. Oxford BioMedica
7.7.1. Business Overview
7.7.2. Product and Service Offering
7.7.3. Financial Overview
7.7.4. Strategic Developments
7.8. Human Stem Cells Institute
7.8.1. Business Overview
7.8.2. Product and Service Offering
7.8.3. Financial Overview
7.8.4. Strategic Developments
7.9. GlaxoSmithKline plc.
7.9.1. Business Overview
7.9.2. Product and Service Offering
7.9.3. Financial Overview
7.9.4. Strategic Developments
7.10. Novartis AG
7.10.1. Business Overview
7.10.2. Product and Service Offering
7.10.3. Financial Overview
7.10.4. Strategic Developments
7.11. AveXis, Inc.
7.11.1. Business Overview
7.11.2. Product and Service Offering
7.11.3. Financial Overview
7.11.4. Strategic Developments
7.12. Editas Medicine
7.12.1. Business Overview
7.12.2. Product and Service Offering
7.12.3. Financial Overview
7.12.4. Strategic Developments
7.13. REGENXBIO Inc.
7.13.1. Business Overview
7.13.2. Product and Service Offering
7.13.3. Financial Overview
7.13.4. Strategic Developments
Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/12336
Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.
Email: firstname.lastname@example.org | +1 407 915 4157